Patent · US Active

Therapeutic compositions

US8716271B2 · kind B2 · utility

6Cited by
4References
26Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 18, 2013
Grant dateMay 6, 2014
Priority date—
Expiry dateFeb 18, 2033

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Ingenol angelate is a potent anticancer agent, and can be stabilized by dissolving it in an aprotic solvent in the presence of an acidic buffer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.